Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 191,736 | 175,331 | 79,448 | 183,898 | 156,139 |
| Depreciation Amortization | 71,078 | 46,990 | 22,443 | 105,049 | 82,149 |
| Income taxes - deferred | -21,653 | -19,544 | -8,255 | -29,465 | -29,143 |
| Accounts receivable | 43,546 | -37,769 | -45,153 | -14,314 | -5,395 |
| Other Working Capital | -47,287 | -96,418 | -63,984 | -56,254 | -29,619 |
| Other Operating Activity | 44,646 | 92,347 | 71,896 | 129,662 | 93,136 |
| Operating Cash Flow | $282,066 | $160,937 | $56,395 | $318,576 | $267,267 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 70,368 | 66,627 | N/A | -301,854 | N/A |
| PPE Investments | -22,154 | -14,741 | -7,217 | -47,928 | -37,218 |
| Net Acquisitions | 25,703 | N/A | N/A | -38,171 | -38,171 |
| Purchase Of Investment | N/A | N/A | -72,790 | -5,000 | -253,156 |
| Sale Of Investment | N/A | N/A | 108,307 | 108,546 | 84,860 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -11,528 | -11,528 |
| Other Investing Activity | 0 | 0 | 0 | -11,528 | -11,528 |
| Investing Cash Flow | $73,917 | $51,886 | $28,300 | $-295,935 | $-255,213 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 37,231 | 21,394 | 10,954 | 57,848 | 53,600 |
| Common Stock Repurchased | -124,276 | -99,276 | -49,412 | -530,486 | -310,486 |
| Dividend Paid | -77,584 | -51,741 | -25,869 | -100,067 | -75,816 |
| Other Financing Activity | -29,385 | -27,566 | -25,766 | -37,853 | -35,429 |
| Financing Cash Flow | $-194,014 | $-157,189 | $-90,093 | $-610,558 | $-368,131 |
| Exchange Rate Effect | 8,819 | 9,415 | 8,504 | -16,744 | -9,698 |
| Beginning Cash Position | 628,371 | 628,371 | 628,371 | 1,233,032 | 1,233,032 |
| End Cash Position | 799,159 | 693,420 | 631,477 | 628,371 | 867,257 |
| Net Cash Flow | $170,788 | $65,049 | $3,106 | $-604,661 | $-365,775 |
| Free Cash Flow | |||||
| Operating Cash Flow | 282,066 | 160,937 | 56,395 | 318,576 | 267,267 |
| Capital Expenditure | -22,154 | -14,741 | -7,217 | -47,928 | -37,218 |
| Free Cash Flow | 259,912 | 146,196 | 49,178 | 270,648 | 230,049 |